A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RYAN SEC filings page.
Ryan Specialty Holdings, Inc. (RYAN) reported $3.2B in revenue over the twelve months to Jun 30, 2026, up 14.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue has scaled rapidly, but higher financing costs and non-cash charges are preventing that growth from reaching bottom-line earnings.
Across FY2021-FY2025, revenue more than doubled while operating margin stayed broadly stable, yet net margin fell from4.6% to2.1% ; this points to pressure below operating income rather than a breakdown in the core operating model. Cash conversion remained tight in FY2025—operating cash flow and free cash flow were nearly identical—yet interest expense climbed from$79.4M in FY2021 to$222.4M , explaining why bottom-line earnings lagged operating profit.
FY2025 current ratio fell below 1.0x while debt-to-equity remained about 5.1x, leaving short-term obligations above current assets and making the capital structure more dependent on liabilities than equity.
Goodwill rose from
Financial Health Signals
Ryan Specialty Holdings, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Ryan Specialty Holdings, Inc. passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Ryan Specialty Holdings, Inc. generates $10.15 in operating cash flow ($643.7M OCF vs $63.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Ryan Specialty Holdings, Inc. earns $2.22 in operating income for every $1 of interest expense ($493.6M vs $222.4M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Ryan Specialty Holdings, Inc. generated $916.6M in revenue in Q2 2026. This represents an increase of 7.2% from the same quarter a year earlier. Against the prior quarter it is up 15.3%.
Ryan Specialty Holdings, Inc.'s EBITDA was $184.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 4.9% from the same quarter a year earlier. Against the prior quarter it is up 87.0%.
Ryan Specialty Holdings, Inc. reported $42.3M in net income in Q2 2026. This represents a decrease of 18.6% from the same quarter a year earlier. Against the prior quarter it is up 139.8%.
Not reported for Q2 2026.
Cash & Balance Sheet
Ryan Specialty Holdings, Inc. generated $291.5M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 17.6% from the same quarter a year earlier. Against the prior quarter it is up 274.1%.
Ryan Specialty Holdings, Inc. held $140.1M in cash against $3.6B in long-term debt as of Q2 2026.
Ryan Specialty Holdings, Inc. paid $0.13 per share in dividends in Q2 2026. This represents an increase of 8.3% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Ryan Specialty Holdings, Inc.'s operating margin was 19.7% in Q2 2026, reflecting core business profitability. This is down 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 7.8 percentage points.
Ryan Specialty Holdings, Inc.'s net profit margin was 4.6% in Q2 2026, showing the share of revenue converted to profit. This is down 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.4 percentage points.
Ryan Specialty Holdings, Inc.'s ROE was 8.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.5 percentage points.
Not reported for Q2 2026.
Capital Allocation
Ryan Specialty Holdings, Inc. spent $260.2M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is up 550.1%.
Ryan Specialty Holdings, Inc. invested $1.6M in capex in Q2 2026, funding long-term assets and infrastructure.
Not reported for Q2 2026.
RYAN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $916.6M+7.2% | $795.2M+15.2% | $751.2M+13.2% | $754.6M+24.8% | $855.2M+23.0% | $690.2M+25.0% | $663.5M+24.5% | $604.7M+20.5% |
| SG&A Expenses | $118.6M+10.8% | $108.8M+2.5% | $122.8M+17.4% | $117.6M+32.6% | $107.0M+29.0% | $106.1M+39.8% | $104.5M+42.1% | $88.7M+28.0% |
| Operating Income | $180.3M-5.6% | $94.6M-5.6% | $91.6M-16.2% | $110.8M+36.0% | $191.1M+16.2% | $100.2M+38.0% | $109.3M+13.5% | $81.5M+16.7% |
| EBITDA | $184.4M-4.9% | $98.7M-4.1% | $369.9M+37.0% | $114.4M+36.3% | $193.9M+16.4% | $102.9M+37.7% | $270.1M+31.4% | $83.9M+16.6% |
| Interest Expense | $56.6M-2.9% | $53.7M-1.4% | $53.2M+9.6% | $56.3M+14.1% | $58.3M+87.4% | $54.5M+85.4% | $48.5M+63.6% | $49.4M+56.8% |
| Income Tax | $22.4M+71.6% | $6.5M-88.3% | $13.4M-49.5% | -$2.8M+68.8% | $13.0M-30.3% | $55.4M+762.6% | $26.5M+3835.5% | -$9.0M-136.1% |
| Net Income | $42.3M-18.6% | $17.6M+163.8% | $8.0M-42.0% | $31.1M+76.7% | $52.0M+11.1% | -$27.6M-267.2% | $13.8M-39.8% | $17.6M+448.5% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
RYAN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.0B+12.6% | $11.0B+11.3% | $10.6B+9.5% | $9.9B+16.2% | $10.6B+28.4% | $9.9B+39.0% | $9.6B+33.2% | $8.5B+31.9% |
| Current Assets | $6.6B+26.1% | $5.6B+21.0% | $5.1B+5.7% | $4.4B+10.6% | $5.3B+2.8% | $4.6B+9.3% | $4.8B+10.5% | $4.0B+12.1% |
| Cash & Equivalents | $140.1M-18.8% | $154.7M-24.0% | $158.3M-70.7% | $153.5M-34.7% | $172.6M-71.8% | $203.5M-69.4% | $540.2M-35.6% | $235.2M-68.8% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $3.2B+4.2% | $3.2B+6.4% | $3.2B+21.9% | $3.1B+33.7% | $3.1B+70.0% | $3.0B+83.6% | $2.6B+60.7% | $2.3B+48.0% |
| Total Liabilities | $11.0B+16.0% | $9.8B+10.9% | $9.3B+8.9% | $8.6B+16.8% | $9.4B+31.2% | $8.8B+43.8% | $8.6B+36.4% | $7.4B+34.5% |
| Current Liabilities | $6.7B+27.2% | $5.5B+24.0% | $5.2B+14.1% | $4.5B+12.4% | $5.2B+11.4% | $4.4B+19.6% | $4.5B+21.5% | $4.0B+33.0% |
| Non-Current Liabilities | $4.3B+2.0% | $4.3B-2.2% | $4.1B+3.0% | $4.2B+22.0% | $4.2B+68.2% | $4.4B+79.9% | $4.0B+58.6% | $3.4B+36.3% |
| Long-Term Debt | $3.6B+4.7% | $3.5B-3.3% | $3.3B+1.9% | $3.3B+26.6% | $3.4B+75.7% | $3.7B+88.0% | $3.2B+66.2% | $2.6B+36.0% |
| Total Equity | $509.4M-16.5% | $636.2M+17.3% | $648.1M+3.3% | $630.5M-0.4% | $610.1M+0.7% | $542.5M-2.1% | $627.7M+12.1% | $632.8M+16.5% |
| Retained Earnings | $145.3M+26.0% | $120.5M+51.9% | $120.4M-2.1% | $128.8M+3.1% | $115.4M-5.1% | $79.3M-10.4% | $122.9M+7.4% | $125.0M+35.6% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable.
RYAN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $293.0M-17.1% | -$167.4M-17.2% | $263.2M+1.4% | $169.7M+68.1% | $353.6M+30.6% | -$142.8M-22.6% | $259.6M+14.4% | $100.9M-4.3% |
| Depreciation & Amortization | $4.1M+43.1% | $4.1M+53.9% | $4.0M+33.4% | $3.6M+46.2% | $2.9M+27.1% | $2.6M+26.9% | $3.0M+20.1% | $2.5M+12.1% |
| Stock-Based Compensation | $21.4M+7.3% | $17.4M-12.7% | N/A | $11.2M-52.3% | $19.9M-4.6% | $19.9M+14.8% | N/A | $23.5M+33.2% |
| Capital Expenditures | $1.6M | $0-100.0% | $0 | $2.4M | $0 | $664K | $0 | $0 |
| Free Cash Flow | $291.5M-17.6% | -$167.4M-16.7% | $263.2M+1.4% | $167.3M+65.8% | $353.6M+30.6% | -$143.5M-23.1% | $259.6M | $100.9M |
| Investing Cash Flow | -$18.7M+59.2% | -$13.3M+97.7% | -$126.8M+73.0% | -$88.2M+91.6% | -$45.9M+79.9% | -$573.0M-7412.3% | -$469.3M-397.7% | -$1.0B-285.0% |
| Financing Cash Flow | $4.0M+103.9% | $86.3M-74.4% | $72.8M-86.6% | -$229.1M-141.4% | -$102.5M-224.4% | $336.8M+3404.0% | $541.5M+2698.8% | $553.2M+402.6% |
| Dividends Paid | $16.5M+7.1% | $16.7M+10.6% | $15.5M+13.2% | $15.0M+11.2% | $15.4M+18.5% | $15.1M-62.3% | $13.7M | $13.5M |
| Share Buybacks | $260.2M | $40.0M | N/A | N/A | $0 | $0 | N/A | N/A |
RYAN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 19.7%-2.7pp | 11.9%-2.6pp | 12.2%-4.3pp | 14.7%+1.2pp | 22.3%-1.3pp | 14.5%+1.4pp | 16.5%-1.6pp | 13.5%-0.4pp |
| Net Margin | 4.6%-1.5pp | 2.2%+6.2pp | 1.1%-1.0pp | 4.1%+1.2pp | 6.1%-0.6pp | -4.0%-7.0pp | 2.1%-2.2pp | 2.9%+3.9pp |
| Return on Equity | 8.3%-0.2pp | 2.8%+7.9pp | 1.2%-1.0pp | 4.9%+2.1pp | 8.5%+0.8pp | -5.1%-8.1pp | 2.2%-1.9pp | 2.8%+3.7pp |
| Return on Assets | 0.4%-0.1pp | 0.2%+0.4pp | 0.1%-0.1pp | 0.3%+0.1pp | 0.5%-0.1pp | -0.3%-0.5pp | 0.1%-0.2pp | 0.2%+0.3pp |
| Current Ratio | 1.000.0x | 1.020.0x | 0.98-0.1x | 1.000.0x | 1.01-0.1x | 1.05-0.1x | 1.05-0.1x | 1.01-0.2x |
| Debt-to-Equity | 7.01+1.4x | 5.55-1.2x | 5.08-0.1x | 5.31+1.1x | 5.59+2.4x | 6.73+3.2x | 5.15+1.7x | 4.18+0.6x |
| Asset Turnover | 0.080.0x | 0.070.0x | 0.070.0x | 0.080.0x | 0.080.0x | 0.070.0x | 0.070.0x | 0.070.0x |
| FCF Margin | 31.8%-9.5pp | -21.1%-0.3pp | 35.0%-4.1pp | 22.2%+5.5pp | 41.3%+2.4pp | -20.8%+0.3pp | 39.1% | 16.7% |
Not reported in any period shown, so not listed: Gross Margin.
Note: The current ratio is below 1.0 (0.98), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Ryan Specialty Holdings, Inc. RYAN | FY2025 | $3.1B | $63.4M | 2.1% | $5.0B | — |
| Fidelity National Financial, Inc. FNF | FY2025 | $14.4B | $602.0M | 4.2% | $10.7B | 28/100 |
| Axis Capital Holders Limited AXS | FY2025 | $6.6B | $1.0B | 15.4% | $7.3B | 36/100 |
| Essent Group LTD ESNT | FY2025 | $1.3B | $690.0M | 54.7% | $5.8B | 54/100 |
| First American Financial Corporation FAF | FY2025 | $7.5B | $621.8M | 8.3% | $6.6B | 20/100 |
| MGIC Investment Corp. MTG | FY2025 | $1.2B | $738.3M | 60.8% | $5.7B | 70/100 |
Where Ryan Specialty Holdings, Inc. Ranks
Frequently Asked Questions
What is Ryan Specialty Holdings, Inc.'s annual revenue?
Ryan Specialty Holdings, Inc. (RYAN) reported $3.1B in total revenue for fiscal year 2025. This represents a 21.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Ryan Specialty Holdings, Inc.'s revenue growing?
Ryan Specialty Holdings, Inc. (RYAN) revenue grew by 21.3% year-over-year, from $2.5B to $3.1B in fiscal year 2025.
Is Ryan Specialty Holdings, Inc. profitable?
Yes, Ryan Specialty Holdings, Inc. (RYAN) reported a net income of $63.4M in fiscal year 2025, with a net profit margin of 2.1%.
What is Ryan Specialty Holdings, Inc.'s EBITDA?
Ryan Specialty Holdings, Inc. (RYAN) had EBITDA of $781.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Ryan Specialty Holdings, Inc. have?
As of fiscal year 2025, Ryan Specialty Holdings, Inc. (RYAN) had $158.3M in cash and equivalents against $3.3B in long-term debt.
What is Ryan Specialty Holdings, Inc.'s operating margin?
Ryan Specialty Holdings, Inc. (RYAN) had an operating margin of 16.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Ryan Specialty Holdings, Inc.'s net profit margin?
Ryan Specialty Holdings, Inc. (RYAN) had a net profit margin of 2.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Ryan Specialty Holdings, Inc.'s return on equity (ROE)?
Ryan Specialty Holdings, Inc. (RYAN) has a return on equity of 9.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Ryan Specialty Holdings, Inc.'s free cash flow?
Ryan Specialty Holdings, Inc. (RYAN) generated $640.7M in free cash flow during fiscal year 2025. This represents a 24.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Ryan Specialty Holdings, Inc.'s operating cash flow?
Ryan Specialty Holdings, Inc. (RYAN) generated $643.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Ryan Specialty Holdings, Inc.'s total assets?
Ryan Specialty Holdings, Inc. (RYAN) had $10.6B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Ryan Specialty Holdings, Inc.'s capital expenditures?
Ryan Specialty Holdings, Inc. (RYAN) invested $3.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Ryan Specialty Holdings, Inc.'s current ratio?
Ryan Specialty Holdings, Inc. (RYAN) had a current ratio of 0.98 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Ryan Specialty Holdings, Inc.'s debt-to-equity ratio?
Ryan Specialty Holdings, Inc. (RYAN) had a debt-to-equity ratio of 5.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Ryan Specialty Holdings, Inc.'s return on assets (ROA)?
Ryan Specialty Holdings, Inc. (RYAN) had a return on assets of 0.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Ryan Specialty Holdings, Inc.'s P/E ratio?
Ryan Specialty Holdings, Inc. (RYAN) trades at 50.2x earnings, its market capitalization divided by net income of $99.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $5.0B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Ryan Specialty Holdings, Inc.'s price-to-sales ratio?
Ryan Specialty Holdings, Inc. (RYAN) trades at 1.5x sales, its market capitalization divided by revenue of $3.2B revenue, trailing 12 months to June 30, 2026. The market capitalization is $5.0B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Ryan Specialty Holdings, Inc.'s Piotroski F-Score?
Ryan Specialty Holdings, Inc. (RYAN) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Ryan Specialty Holdings, Inc.'s earnings high quality?
Ryan Specialty Holdings, Inc. (RYAN) has an earnings quality ratio of 10.15x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Ryan Specialty Holdings, Inc. cover its interest payments?
Ryan Specialty Holdings, Inc. (RYAN) has an interest coverage ratio of 2.22x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.